Delivery Order SPE2DB22D3016-SPE2DB25FBGC6
- Not listed
- The Defense Logistics Agency awarded a $1,819.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Januvia 100 mg tablets (90-count units). This non-set-aside contract, with an ultimate completion date of August 14, 2025, represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- The Defense Logistics Agency awarded a $1,117.20 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg, a diabetes management medication. This competitively awarded, firm fixed-price contract was executed on July 25, 2025, with an ultimate completion date of July 28, 2025. The contract carries no set-aside designation and represents a discrete order fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $19,581.28 to AmerisourceBergen Drug Corp for 1,000 tablets of Januvia 100 mg, with an ultimate completion date of August 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $7,401.38 delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Januvia 100 mg, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $5,078.66 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Januvia 100 mg tablets (90-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 11, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $20,394.12 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Januvia 100 mg, a diabetes medication. The contract is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025, and was competitively awarded without any set-aside designation. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,455.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 90 tablets of Januvia 50 mg on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitive award, which includes no set-aside designation, represents a pharmaceutical supply delivery from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $23,238.44 firm fixed price delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Januvia 100 mg, with an ultimate completion date of August 1, 2025. This competitively awarded, non-set-aside contract was issued on July 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Januvia 100 mg tablets (90-count units) under a firm fixed-price contract valued at $10,936.33. This non-set-aside award is a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is listed as Conshohocken,...
- The Defense Logistics Agency awarded a $3,683.24 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Januvia 100 mg tablets (90-count) under a firm fixed-price contract. The order, which has an ultimate completion date of July 25, 2025, will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively procured with no set-aside designation and operates as a child contract under a larger vehicle. This...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBGC6Delivery Order
The Defense Logistics Agency awarded a $25,361.92 delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Januvia 100 mg, with an ultimate completion date of August 26, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and primary distribution hub for federal pharmaceutical procurements. As a major pharmaceutical distributor and critical vendor for federal medical supply chains, AmerisourceBergen Drug Corp supplies the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with a comprehensive range of brand-name and generic medications, vaccines, and medical supplies. This delivery order for Januvia, a diabetes medication, exemplifies the company's ongoing role in supporting military and veteran healthcare programs through the DLA's Pharmaceutical Prime Vendor program, which enables flexible procurement of pharmaceutical products to meet federal medical requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.4k | 8/25/25 |